Matinas BioPharma (MTNB)

• Market cap: $1.72M
• 1 day: -2.4%
• 5 days: -16.12%
• 1 month: -57.26%
• 3 months: -60.53%
• 6 months: -54.51%
• Year to date: -56.71%
• 1 year: -70.18%
• 5 years: -99.31%
• 10 years: -99.86%
• Sector: Healthcare
• Industry: Drug Manufacturers - General

About: Matinas BioPharma Holdings Inc is a clinical-stage biopharmaceutical company with a focus on identifying and developing novel pharmaceutical products. The firm's pipeline includes MAT2203, MAT2501, and others. Its LNC platform enables safe, intracellular, oral- delivery of small molecules and small oligonucleotides.

Employees: 2